OABINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as OABIW
OmniAb, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.69+0.10 (+2.18%)
Close on Oct 19, 2026
- Market cap
- $604.05M
- P/E (TTM)
- –
- Dividend yield
- –
OmniAb, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License and milestone revenue | $9.52M | $12.03M | $5.89M | $616.00K | $1.24M | $2.02M | $8.65M | $1.38M | $3.13M | $716.00K | $1.71M | $2.01M | 70.9% | +666.1% |
| Service revenue | $2.47M | $2.11M | $2.24M | $1.19M | $1.94M | $1.90M | $2.53M | $2.48M | $4.17M | $2.77M | $2.76M | $3.02M | 18.4% | +27.7% |
| xPloration revenue | $1.16M | $54.00K | $30.00K | $74.00K | $608.00K | $42.00K | $0 | $0 | $0 | – | – | – | 8.7% | +91.0% |
| Royalty revenue | $266.00K | $241.00K | $218.00K | $361.00K | $111.00K | $188.00K | – | $318.00K | $318.00K | $319.00K | $354.00K | $451.00K | 2.0% | +139.6% |
By region
From the segment and revenue-disaggregation notes of OmniAb's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.